Industry sponsorship and research outcome

A Lundh, J Lexchin, B Mintzes… - … of systematic reviews, 2017 - cochranelibrary.com
Background Clinical research affecting how doctors practice medicine is increasingly
sponsored by companies that make drugs and medical devices. Previous systematic …

Practitioner review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: A systematic …

R Rodrigues, MC Lai, A Beswick… - Journal of Child …, 2021 - Wiley Online Library
Background Clinically significant attention‐deficit/hyperactivity disorder (ADHD) symptoms
are common and impairing in children and youth with autism spectrum disorder (ASD). The …

Immune abnormalities in autism spectrum disorder—could they hold promise for causative treatment?

D Gładysz, A Krzywdzińska, KK Hozyasz - Molecular neurobiology, 2018 - Springer
Autism spectrum disorders (ASD) are characterized by impairments in language and
communication development, social behavior, and the occurrence of stereotypic patterns of …

Social decision making in autism: On the impact of mirror neurons, motor control, and imitative behaviors

R Khalil, R Tindle, T Boraud… - CNS neuroscience & …, 2018 - Wiley Online Library
Summary The Mirror Neuron System (MNS) plays a crucial role in action perception and
imitative behavior, which is suggested to be impaired in Autism Spectrum Disorders (ASD s) …

Antipsychotic use with and without comorbid psychiatric diagnosis among adults with intellectual and developmental disabilities

Y Lunsky, W Khuu, M Tadrous… - The Canadian …, 2018 - journals.sagepub.com
Objective: Antipsychotic use is controversial in the management of adults with intellectual
and developmental disabilities (IDD) because of inconclusive evidence for efficacy in the …

Pharmacological management of psychopathology in people with intellectual disabilities and/or autism spectrum disorder

S Deb, M Roy, B Limbu - BJPsych Advances, 2023 - cambridge.org
On average, 49–63% of people with intellectual disabilities and/or autism spectrum disorder
(ASD) are prescribed psychotropic medications to treat psychopathology, including …

Randomised controlled trials of antipsychotics for people with autism spectrum disorder: a systematic review and a meta-analysis

S Deb, M Roy, B Limbu, BA Brizard… - Psychological …, 2023 - cambridge.org
BackgroundDespite unclear evidence to support the long-term use of antipsychotics to treat
challenging (problem) behaviours in people with autism in the absence of a psychiatric …

Randomised controlled trials of antidepressant and anti-anxiety medications for people with autism spectrum disorder: systematic review and meta-analysis

S Deb, M Roy, R Lee, M Majid, B Limbu… - BJPsych Open, 2021 - cambridge.org
BackgroundAlthough widely used, the current evidence for the efficacy of antidepressant
and anti-anxiety medications for people with autism spectrum disorder (ASD) is limited and …

[HTML][HTML] Treatment of aggression in adults with autism spectrum disorder: A review

DS Im - Harvard review of psychiatry, 2021 - journals.lww.com
Background Autism spectrum disorder (ASD) is a neurodevelopmental disorder
characterized by markedly impaired social interaction, impaired communication, and …

Evidence of the dysbiotic effect of psychotropics on gut microbiota and capacity of probiotics to alleviate related dysbiosis in a model of the human colon

Y Ait Chait, W Mottawea, TA Tompkins… - International Journal of …, 2023 - mdpi.com
Growing evidence indicates that non-antibiotic therapeutics significantly impact human
health by modulating gut microbiome composition and metabolism. In this study, we …